← Back to Search

Neurotoxin

Abobotulinum toxin A for Limb Tremor

Phase 4
Recruiting
Led By David M Simpson, MD
Research Sponsored by David M. Simpson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 18
Awards & highlights

Study Summary

This trial will test the use of botulinum toxin to improve task-dependent upper limb tremor in 25 patients. The team hopes to show that the toxin is effective and tolerable, and to use the data to power a future clinical trial.

Eligible Conditions
  • Limb Tremor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 18
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 18 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient's Impression of Change
Secondary outcome measures
Physician Global Impression of Change

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Abobotulinum toxin AActive Control1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

IpsenIndustry Sponsor
345 Previous Clinical Trials
73,203 Total Patients Enrolled
David M. SimpsonLead Sponsor
1 Previous Clinical Trials
12 Total Patients Enrolled
David M Simpson, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
2 Previous Clinical Trials
321 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Movement DisordersJournal
Movement Disorders in Musicians
Jankovic, Joseph, and Aidin Ashoori. 2008. “Movement Disorders in Musicians”. Movement Disorders. Wiley. doi:10.1002/mds.22255.
Movement DisordersJournal
The Natural History of Embouchure Dystonia
Frucht, Steven J., Stanley Fahn, Paul E. Greene, Christopher O'Brien, Michael Gelb, Daniel D. Truong, John Welsh, Stewart Factor, and Blair Ford. 2001. “The Natural History of Embouchure Dystonia”. Movement Disorders. Wiley. doi:10.1002/mds.1167.
Archives of NeurologyJournal
Approach to the Treatment of Limb Disorders with Botulinum Toxin A
Pullman, Seth L.. 1996. “Approach to the Treatment of Limb Disorders with Botulinum Toxin A”. Archives of Neurology. American Medical Association (AMA). doi:10.1001/archneur.1996.00550070055012.
ScienceJournal
Increased Cortical Representation of the Fingers of the Left Hand in String Players
Elbert, Thomas, Christo Pantev, Christian Wienbruch, Brigitte Rockstroh, and Edward Taub. 1995. “Increased Cortical Representation of the Fingers of the Left Hand in String Players”. Science. American Association for the Advancement of Science (AAAS). doi:10.1126/science.270.5234.305.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top